Jayvardhan Pandit

Jayvardhan Pandit

Auto-generated profile, based on publicly available information

Jayvardhan Pandit

Pfizer Global Research & Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
PBPhilip G. Board
Philip G. Board
MCMarjorie Coggan
Marjorie Coggan
GCGareth Chelvanayagam
Gareth Chelvanayagam
SESimon Easteal
Simon Easteal
LJLars Sommer Jermiin
Lars Sommer Jermiin
JPJayvardhan Pandit
Jayvardhan Pandit
A new class of glutathione transferases has been discovered by analysis of the expressed sequence tag data base and sequence alignment. Glutathione S-transferases (GSTs) of the new class, named Omega, exist in several mammalian species andCaenorhabditis elegans. In humans, GSTO 1-1 is expressed in most tissues and exhibits glutathione-dependent thiol transferase and dehydroascorbate reductase activities characteristic of the glutaredoxins. The structure of GSTO 1-1 has been determined at 2.0-Å resolution and has a characteristic GST fold (Protein Data Bank entry code 1eem). The Omega class GSTs exhibit an unusual N-terminal extension that abuts the C terminus to form a novel structural unit. Unlike other mammalian GSTs, GSTO 1-1 appears to have an active site cysteine that can form a disulfide bond with glutathione.

1 September 2000 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JPJayvardhan Pandit
Jayvardhan Pandit
DDDennis E. Danley
Dennis E. Danley
GSGayle K. Schulte
Gayle K. Schulte
SMStacy Mazzalupo
Stacy Mazzalupo
TPThomas A. Pauly
Thomas A. Pauly
HHH. James Harwood
H. James Harwood
Squalene synthase catalyzes the biosynthesis of squalene, a key cholesterol precursor, through a reductive dimerization of two farnesyl diphosphate (FPP) molecules. The reaction is unique when compared with those of other FPP-utilizing enzymes and proceeds in two distinct steps, both of which involve the formation of carbocationic reaction intermediates. Because FPP is located at the final branch point in the isoprenoid biosynthesis pathway, its conversion to squalene through the action of squalene synthase represents the first committed step in the formation of cholesterol, making it an attractive target for therapeutic intervention. We have determined, for the first time, the crystal structures of recombinant human squalene synthase complexed with several different inhibitors. The structure shows that SQS is folded as a single domain, with a large channel in the middle of one face. The active sites of the two half-reactions catalyzed by the enzyme are located in the central channel, which is lined on both sides by conserved aspartate and arginine residues, which are known from mutagenesis experiments to be involved in FPP binding. One end of this channel is exposed to solvent, whereas the other end leads to a completely enclosed pocket surrounded by conserved hydrophobic residues. These observations, along with mutagenesis data identifying residues that affect substrate binding and activity, suggest that two molecules of FPP bind at one end of the channel, where the active center of the first half-reaction is located, and then the stable reaction intermediate moves into the deep pocket, where it is sequestered from solvent and the second half-reaction occurs. Five alpha helices surrounding the active center are structurally homologous to the active core in the three other isoprenoid biosynthetic enzymes whose crystal structures are known, even though there is no detectable sequence homology.


20 November 1992 in Science
Verified
Journal Article
Open access
PDF file
JPJayvardhan Pandit
Jayvardhan Pandit
ABAndrew Bohm
Andrew Bohm
JJJarmila Jancarik
Jarmila Jancarik
RHRobert Halenbeck
Robert Halenbeck
KKKirston Koths
Kirston Koths
SKSung-Hou Kim
Sung-Hou Kim
Macrophage colony-stimulating factor (M-CSF) triggers the development of cells of the monocyte-macrophage lineage and has a variety of stimulatory effects on mature cells of this class. The biologically active form of M-CSF is a disulfide-linked dimer that activates an intrinsic tyrosine kinase activity on the M-CSF receptor by inducing dimerization of the receptor molecules. The structure of a recombinant human M-CSF dimer, determined at 2.5 angstroms by x-ray crystallography, contains two bundles of four α helices laid end-to-end, with an interchain disulfide bond. Individual monomers of M-CSF show a close structural similarity to the cytokines granulocyte-macrophage colony-stimulating factor and human growth hormone. Both of these cytokines are monomeric in their active form, and their specific receptors lack intrinsic tyrosine kinase activity. The similarity of these structures suggests that the receptor binding determinants for all three cytokines may be similar.

27 October 2009 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
JPJayvardhan Pandit
Jayvardhan Pandit
MFMichael D. Forman
Michael D. Forman
KFKimberly F. Fennell
Kimberly F. Fennell
KDKeith S. Dillman
Keith S. Dillman
FMFrank Menniti
Frank Menniti
We report the X-ray crystal structure of a phosphodiesterase (PDE) that includes both catalytic and regulatory domains. PDE2A (215–900) crystallized as a dimer in which each subunit had an extended organization of regulatory GAF-A and GAF-B and catalytic domains connected by long α-helices. The subunits cross at the GAF-B/catalytic domain linker, and each side of the dimer contains in series the GAF-A and GAF-B of one subunit and the catalytic domain of the other subunit. A dimer interface extends over the entire length of the molecule. The substrate binding pocket of each catalytic domain is occluded by the H-loop. We deduced from comparisons with structures of isolated, ligand-bound catalytic subunits that the H-loop swings out to allow substrate access. However, in dimeric PDE2A (215–900), the H-loops of the two catalytic subunits pack against each other at the dimer interface, necessitating movement of the catalytic subunits to allow for H-loop movement. Comparison of the unliganded GAF-B of PDE2A (215–900) with previous structures of isolated, cGMP-bound GAF domains indicates that cGMP binding induces a significant shift in the GAF-B/catalytic domain linker. We propose that cGMP binding to GAF-B causes movement, through this linker region, of the catalytic domains, such that the H-loops no longer pack at the dimer interface and are, instead, free to swing out to allow substrate access. This increase in substrate access is proposed as the basis for PDE2A activation by cGMP and may be a general mechanism for regulation of all PDEs.

9 December 2014 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
AMAndreas Maderna
Andreas Maderna
MDMatthew Doroski
Matthew Doroski
CSChakrapani Subramanyam
Chakrapani Subramanyam
APAlexander Porte
Alexander Porte
CLCarolyn A. Leverett
Carolyn A. Leverett
COChristopher J. O’dOnnell
Christopher J. O’dOnnell